Iris registration is a good compensator of cyclotorsion
March 31st 2008Compensation of cyclotorsion using iris registration can be helpful in decreasing misalignment of the axis of correction and in improving the overall outcome of LASIK, according to a study to be published in the April 2008 issue of the Journal of Cataract & Refractive Surgery.
Higher risk of cardiovascular mortality linked with timolol
March 28th 2008Cardiovascular mortality tends to increase in black persons with diagnosed and treated open-angle glaucoma (OAG) and ocular hypertension (OH), and the risk of death and cardiovascular mortality are increased further in those patients treated with timolol, according to a paper published in the March 11, 2008 issue of the Archives of Ophthalmology.
DCT better than GAT in assessing glaucomatous damage
March 28th 2008Dynamic contour tonometry (DCT) provides a more accurate measure of glaucomatous visual field loss and intraocular pressure (IOP) when compared with Goldmann applanation tonometry (GAT), according to a study published in the December 2007 issue of the Journal of Glaucoma.
Office safer than the operating theatre for intravitreal injections
March 26th 2008The incidence of endophthalmitis following injections of anti-VEGF drugs is lower when the injections are given in an office setting than the rates reported from clinical trials, which require a more extensive pre-injection regimen.
Alcon releases new data for glaucoma candidate
March 14th 2008Alcon has announced positive efficacy and safety results from its second controlled proof of concept clinical study of anecortave acetate administered as an anterior juxtascleral depot in the sub-Tenon's space to reduce intraocular pressure (IOP) in patients with open-angle glaucoma.
Fewer Lucentis injections with new regimen
March 12th 2008Preliminary results of a study using the NSAID Xibrom (bromfenac ophthalmic solution 0.09%; ISTA Pharmaceuticals) therapy in combination with Lucentis (ranibizumab; Novartis) in patients with wet age-related macular degeneration (AMD), suggests that it may result in fewer injections being required.
Cataract incision size is just right thanks to new technology
March 10th 2008Incision sizes needed to remove cataracts have been significantly reduced by new technology, such as the vision enhancement system (Stellaris; Bausch & Lomb) which allows surgeons to make two 1.8 mm cuts on either side of the eye.
Resistance fuelling contact lens infections
March 4th 2008A study published in the January issue of Antimicrobial Agents & Chemotherapy, has found that the high proportion of corneal infections linked to contact lens solutions are fuelled and made resistant to treatment by the formation of a highly resistant structure of microbial cells held together with a glue-like matrix material, called biofilms.